Researchers announcing their preliminary results at the American Society of Clinical Oncology conference in Chicago this week say they have made major steps forward towards “liquid biopsies”.

In 89 percent of patients, at least one genetic change detected in the tumor was also found in the blood.

Watch the video below or read more here